dihexa hgf/c-met potentiator

dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Correlation between hypoxia and HGF/c-MET

Name: dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Correlation between hypoxia and HGF/c-MET
Brand: tmdnewgeneration.cz
SKU: 9933087528
Price: 29.59 USD
Availability: InStock
Rating: 4.45 (27 reviews)

Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic What is Dihexa? Benefits, mechanism, and uses for cognitive function Cenegenics

SKU: 9933087528 · From tmdnewgeneration.cz

4.5

USD29.59 USD61.59

Pay in 4 interest-free payments of $7.40 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

Besides, HSPA1, previously known anti-proliferative factor with JAK/STAT pathway involved, is additionally reported to mediate the angiogenic effect of interleukin-28A in vitro and in vivo via the eNOS/AKT signaling pathway and the activator protein-1/nuclear factor-B/matrix metalloproteinase-2 (AP-1/NF-B/MMP-2) cascade (Song et al., 2025)